Dr Reddys Laboratories Marks 25 Years of NYSE Listing with Closing Bell Ceremony SCHL Q1 2026 Earnings NarrowerThanExpected Loss Boosts Sentiment Despite Flat Revenue ZeroDown Mortgages Exploring Homebuying Options with No Down Payment YRD Q2 2025 Earnings Strong EPS of 409 Reported But Stock Declines 442 ZH Q4 2025 Earnings EPS Misses Estimates by Wide Margin as Stock Edges Higher BDTX Q1 2026 Earnings Narrower Loss Surpasses Estimates Amid Clinical Progress TX Q1 2026 Earnings Strong Earnings Beat Despite Revenue Uncertainty Stock Slightly Down PAYP Q1 2026 Earnings Significant EPS Miss Weighs on Investor Sentiment COYA Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Reaction SLNG Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges